Swiss National Bank’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.92M | Buy |
|
|||||
|
2025
Q2 | $3.4M | Sell |
|
|||||
|
2025
Q1 | $2.86M | Sell |
|
|||||
|
2024
Q4 | $2.91M | Buy |
|
|||||
|
2024
Q3 | $2.77M | Hold |
|
|||||
|
2024
Q2 | $2.25M | Hold |
|
|||||
|
2024
Q1 | $1.85M | Sell |
|
|||||
|
2023
Q4 | $2.24M | Sell |
|
|||||
|
2023
Q3 | $2.94M | Buy |
|
|||||
|
2023
Q2 | $2.89M | Buy |
|
|||||
|
2023
Q1 | $3.36M | Sell |
|
|||||
|
2022
Q4 | $5.15M | Buy |
|
|||||
|
2022
Q3 | $5.55M | Buy |
|
|||||
|
2022
Q2 | $4.6M | Buy |
|
|||||
|
2022
Q1 | $6.92M | Buy |
|
|||||
|
2021
Q4 | $5.44M | Hold |
|
|||||
|
2021
Q3 | $5.64M | Buy |
|
|||||
|
2021
Q2 | $6.16M | Sell |
|
|||||
|
2021
Q1 | $4.1M | Buy |
|
|||||
|
2020
Q4 | $2.97M | Buy |
|
|||||
|
2020
Q3 | $1.35M | Buy |
|
|||||
|
2020
Q2 | $1.84M | Buy |
|
|||||
|
2020
Q1 | $598K | Buy |
|
|||||
|
2019
Q4 | $980K | Buy |
|
|||||
|
2019
Q3 | $401K | Hold |
|
|||||
|
2019
Q2 | $530K | Hold |
|
|||||
|
2019
Q1 | $1.14M | Buy |
|
|||||
|
2018
Q4 | $1.09M | Buy |
|
|||||
|
2018
Q3 | $916K | Hold |
|
|||||
|
2018
Q2 | $688K | Sell |
|
|||||
|
2018
Q1 | $817K | Hold |
|
|||||
|
2017
Q4 | $841K | Hold |
|
|||||
|
2017
Q3 | $898K | Buy |
|
|||||
|
2017
Q2 | $636K | Hold |
|
|||||
|
2017
Q1 | $960K | Buy |
|
|||||
|
2016
Q4 | $610K | Hold |
|
|||||
|
2016
Q3 | $425K | Hold |
|
|||||
|
2016
Q2 | $273K | Hold |
|
|||||
|
2016
Q1 | $263K | Buy |
|
|||||
|
2015
Q4 | $809K | Hold |
|
|||||
|
2015
Q3 | $894K | Buy |
|
|||||
|
2015
Q2 | $1.02M | Buy |
|
|||||
|
2015
Q1 | $599K | Hold |
|
|||||
|
2014
Q4 | $806K | Buy |
|
|||||
|
2014
Q3 | $625K | Sell |
|
|||||
|
2014
Q2 | $954K | Buy |
|
|||||
|
2014
Q1 | $584K | Buy |
|
|||||
|
2013
Q4 | $333K | Buy |
|